Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 4;9(9):CD009710.
doi: 10.1002/14651858.CD009710.pub3.

Homeopathy for treatment of irritable bowel syndrome

Emily J Peckham  1 , Katy Cooper, E Rachel Roberts, Anurag Agrawal, Sally Brabyn, Garry Tew
Affiliations

Homeopathy for treatment of irritable bowel syndrome

Emily J Peckham et al. Cochrane Database Syst Rev. .

Abstract

Background: Irritable bowel syndrome (IBS) is a common, chronic disorder that leads to decreased health-related quality of life and work productivity. A previous version of this review was not able to draw firm conclusions about the effectiveness of homeopathic treatment for IBS and recommended that further high quality RCTs were conducted to explore the clinical and cost effectiveness of homeopathic treatment for IBS. Two types of homeopathic treatment were evaluated in this systematic review: 1. Clinical homeopathy where a specific remedy is prescribed for a specific condition; 2. Individualised homeopathic treatment, where a homeopathic remedy based on a person's individual symptoms is prescribed after a detailed consultation.

Objectives: To assess the effectiveness and safety of homeopathic treatment for IBS.

Search methods: For this update we searched MEDLINE, CENTRAL, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED), the Cochrane IBD Group Specialised Register and trials registers from inception to 31 August 2018.

Selection criteria: Randomised controlled trials (RCTs), cohort and case-control studies that compared homeopathic treatment with placebo, other control treatments, or usual care, in adults with IBS were considered for inclusion.

Data collection and analysis: Two authors independently assessed the risk of bias and extracted data. The primary outcome was global improvement in IBS as measured by an IBS symptom severity score. Secondary outcomes included quality of life, abdominal pain, stool frequency, stool consistency, and adverse events. The overall certainty of the evidence supporting the primary and secondary outcomes was assessed using the GRADE criteria. We used the Cochrane risk of bias tool to assess risk of bias. We calculated the mean difference (MD) and 95% confidence interval (CI) for continuous outcomes and the risk ratio (RR) and 95% CI for dichotomous outcomes.

Main results: Four RCTs (307 participants) were included. Two studies compared clinical homeopathy (homeopathic remedy, asafoetida or asafoetida plus nux vomica) to placebo for IBS with constipation (IBS-C). One study compared individualised homeopathic treatment (consultation plus remedy) to usual care for the treatment of IBS in female patients. One study was a three armed RCT comparing individualised homeopathic treatment to supportive listening or usual care. The risk of bias in three studies (the two studies assessing clinical homeopathy and the study comparing individualised homeopathic treatment to usual care) was unclear on most criteria and high for selective reporting in one of the clinical homeopathy studies. The three armed study comparing individualised homeopathic treatment to usual care and supportive listening was at low risk of bias in four of the domains and high risk of bias in two (performance bias and detection bias).A meta-analysis of the studies assessing clinical homeopathy, (171 participants with IBS-C) was conducted. At short-term follow-up of two weeks, global improvement in symptoms was experienced by 73% (46/63) of asafoetida participants compared to 45% (30/66) of placebo participants (RR 1.61, 95% CI 1.18 to 2.18; 2 studies, very low certainty evidence). In the other clinical homeopathy study at two weeks, 68% (13/19) of those in the asafoetida plus nux vomica arm and 52% (12/23) of those in the placebo arm experienced a global improvement in symptoms (RR 1.31, 95% CI 0.80 to 2.15; very low certainty evidence). In the study comparing individualised homeopathic treatment to usual care (N = 20), the mean global improvement score (feeling unwell) at 12 weeks was 1.44 + 4.55 (n = 9) in the individualised homeopathic treatment arm compared to 1.41 + 1.97 (n=11) in the usual care arm (MD 0.03; 95% CI -3.16 to 3.22; very low certainty evidence).In the study comparing individualised homeopathic treatment to usual care, the mean IBS symptom severity score at 6 months was 210.44 + 112.4 (n = 16) in the individualised homeopathic treatment arm compared to 237.3 + 110.22 (n = 60) in the usual care arm (MD -26.86, 95% CI -88.59 to 34.87; low certainty evidence). The mean quality of life score (EQ-5D) at 6 months in homeopathy participants was 69.07 (SD 17.35) compared to 63.41 (SD 23.31) in usual care participants (MD 5.66, 95% CI -4.69 to 16.01; low certainty evidence).For In the study comparing individualised homeopathic treatment to supportive listening, the mean IBS symptom severity score at 6 months was 210.44 + 112.4 (n = 16) in the individualised homeopathic treatment arm compared to 262 + 120.72 (n = 18) in the supportive listening arm (MD -51.56, 95% CI -129.94 to 26.82; very low certainty evidence). The mean quality of life score at 6 months in homeopathy participants was 69.07 (SD 17.35) compared to 63.09 (SD 24.38) in supportive listening participants (MD 5.98, 95% CI -8.13 to 20.09; very low certainty evidence).None of the included studies reported on abdominal pain, stool frequency, stool consistency, or adverse events.

Authors' conclusions: The results for the outcomes assessed in this review are uncertain. Thus no firm conclusions regarding the effectiveness and safety of homeopathy for the treatment of IBS can be drawn. Further high quality, adequately powered RCTs are required to assess the efficacy and safety of clinical and individualised homeopathy for IBS compared to placebo or usual care.

PubMed Disclaimer

Conflict of interest statement

EJP has contributed to the design and management of one of the included RCTs. EJP is a homeopath.

GT: None known.

SB: None known.

KC: None known.

AA: None known.

Figures

1
1
Study flow diagram.
2
2
Methodological quality summary: review authors' judgments about each methodological quality item for each included study.
1.1
1.1. Analysis
Comparison 1 Homeopathy versus placebo, Outcome 1 Homeopathy versus placebo.
2.1
2.1. Analysis
Comparison 2 Homeopathy versus usual care, Outcome 1 Global improvement (feeling unwell).
3.1
3.1. Analysis
Comparison 3 Homeopathy plus usual care versus usual care, Outcome 1 Global improvement (IBS‐SSS).
3.2
3.2. Analysis
Comparison 3 Homeopathy plus usual care versus usual care, Outcome 2 Quality of life.
4.1
4.1. Analysis
Comparison 4 Homeopathy plus usual care versus supportive listening plus usual care, Outcome 1 Global improvement (IBS‐SSS).
4.2
4.2. Analysis
Comparison 4 Homeopathy plus usual care versus supportive listening plus usual care, Outcome 2 Quality of life.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Owen 1990 {published data only}
    1. Lecoyte T, Owen D, Shepherd H, Letchworth A, Mullee M. An investigation into the homeopathic treatment of patients with irritable bowel syndrome. Proceedings of the 48th LMHI Congress. Vienna, Austria, 1993.
    1. Owen D. An investigation into the homoeopathic treatment of patients with irritable bowel syndrome. Congress of the Faculty of Homoeopathy. Windermere, 1990.
Peckham 2014 {published data only (unpublished sought but not used)}
    1. Peckham E, Raw J, Relton C. Exploring the effectiveness of homeopathic treatment for irritable bowel syndrome. Homeopathy 2014;103(1):90‐1. - PubMed
    1. Peckham EJ, Relton C, Raw J, Walters C, Thomas K, Smith C, et al. Interim results of a randomised controlled trial of homeopathic treatment for irritable bowel syndrome. Homeopathy 2014;103(3):172‐7. - PubMed
Rahlfs 1976 {published data only}
    1. Rahlfs VW, Mossinger P. Treatment of irritable colon. A multicenter placebo‐controlled double‐blind study in general practice [Ein multizentrischer plazebo‐kontrollierter doppelblindversuch in der allgemeinen praxis]. Arzneimittel Forschung 1976;26(12):2230‐4. - PubMed
Rahlfs 1979 {published data only}
    1. Rahlfs VW, Mossinger P. Asa foetida in the treatment of the irritable colon; a double blind trial [Asa foetida bei colon irritabile]. Deutsche Medizinische Wochenschrift 1979;104(4):140‐3. - PubMed

References to studies excluded from this review

Aleem 2000 {published data only}
    1. Aleem SM. Colo‐rectal disorders. National Journal of Homeopathy 2000;2(4):259‐61.
Anonymous 2005 {published data only}
    1. Anonymous. Homeopathy and placebo [Omeopatia e placebo]. Medico e Bambino 2005;24(7):415.
Anonymous 2009 {published data only}
    1. Anonymous. Homoeopathy associated with improvements in health. Australian Journal of Pharmacy 2009;90:75.
Bauer 2014 {published data only}
    1. Bauer BA, Litin JC, Bundrick JB. Clinical pearls in complementary and integrative medicine (cim). Disease‐a‐month 2014;60(7):323‐331. - PubMed
Bhagat 2010 {published data only}
    1. Bhagat J. Case study and management of irritable bowel syndrome. Homoeopathic Heritage International 2010;35(1):18‐21.
Bhattacharjee 2010 {published data only}
    1. Bhattacharjee J. Irritable bowel syndrome ‐ a menace in disguise. Homoeopathic Heritage International 2010;35(1):34‐9.
Chen 2015 {published data only}
    1. Chen JDZ, Yin J, Takahashi T, Hou X. Complementary and Alternative Therapies for Functional Gastrointestinal Diseases. Evidence‐based Complementary and Alternative Medicine 2015;138645. - PMC - PubMed
Cherniack 2013 {published data only}
    1. Cherniack EP. Use of complementary and alternative medicine to treat constipation in the elderly. Geriatrics and Gerontology International 2013;13(3):533‐538. - PubMed
Chimthanawala 2004 {published data only}
    1. Chimthanawala D. Irritable bowel syndrome ‐ a few cases. National Journal of Homoeopathy 2004;6(2):102‐4.
Diamond 2005 {published data only}
    1. Diamond JA, Diamond JW. Common functional bowel problems. Advance for Nurse Practitioners 2005;13(5):31‐34,72. - PubMed
Elio 2014 {published data only}
    1. Elio R, Marco P, Paola B, Marialessandra P, Mariella DS, Monia P, et al. Homoeopathy in the public health system: Outcome data from the homoeopathic clinic of the Campo di Marte Hospital, Lucca, Italy (1998‐2010). European Journal of Integrative Medicine 2014;6(1):39‐47.
Feldhaus 2000 {published data only}
    1. Feldhaus HW. Comprehensive therapy recommendation for irritable bowel syndrome [Ganzheitliche therapieempfehlung bei reizdarm: Behandlungsvorschlag aus unserem preisratsel]. Arztezeitschrift fur Naturheilverfahren 2000;4(6):336‐7.
Gamble 2007 {published data only}
    1. Gamble J. Case insights series. A study on irritable bowel syndrome. Similia: Journal of the Australian Homoeopathic Association 2007;19(1):19‐21.
Gebhardt 1988 {published data only}
    1. Gebhardt KH. Homeopathy for catarrh of the mucous membrane of the air routes, intestines and urinary tract [Homootherapie der schleimhautkatarrhe der luftwege, speisewege und harnwege]. Erfahrungsheilkunde 1988;37(4):202‐4.
Gray 1998 {published data only}
    1. Gray J. How I treat irritable bowel disease: a survey of 25 patients. British Homoeopathic Journal 1998;87(4):195‐202.
Greeson 2008 {published data only}
    1. Greeson JM, Rosenzweig S, Halbert SC, Cantor IS, Keener MT, Brainard GC. Integrative medicine research at an academic medical centre: Patient characteristics and health‐related quality‐of‐life outcomes. Journal of Alternative and Complementary Medicine 2008;14(6):763‐7. - PMC - PubMed
Grundmann 2014 {published data only}
    1. Grundmann O, Yoon SL. Complementary and alternative medicines in irritable bowel syndrome: an integrative view. World Journal of Gastroenterology 2014;20(2):346‐62. - PMC - PubMed
Innes 2000 {published data only}
    1. Innes MA, Greenfield SM, Hunton M. Using case studies for prescribing research ‐ an example from homoeopathic prescribing. Journal of Clinical Pharmacy and Therapeutics 2000;25(6):399‐409. - PubMed
Jagose 2004 {published data only}
    1. Jagose A. The efficacy of homoeopathy in IBS. National Journal of Homoeopathy 2004;6(2):106‐7.
Jones 1996 {published data only}
    1. Jones A. Homoeopathic case studies: irritable bowel syndrome. Positive Health 1996;16:30.
Jones 1997 {published data only}
    1. Jones A. Irritable bowel syndrome. Homoeopathy 1997;47(5):101‐2.
Jones 1999 {published data only}
    1. Jones A. Homeopathic case studies: Nux Vomica for bowel symptoms. Positive Health 1999;37:25.
Krishendu 2010 {published data only}
    1. Krishendu. Irritable bowel syndrome ‐ a homeopathic perspective. Homoeopathic Heritage International 2010;35(1):26‐30.
Lobo 2000 {published data only}
    1. Lobo A. IBS: a constitutional approach. National Journal of Homoeopathy 2000;2(4):262a‐d.
Master 2008 {published data only}
    1. Master FJ. From the editor's desk. Homoeopatic approaches to irritable bowel syndrome. Homoeopathic Heritage International 2008;33(10):4‐5.
Mohan 2006 {published data only}
    1. Mohan G, Kishore KC, Ratna SA. Irritable bowel syndrome: "A challenge in medical practice". National Journal of Homoeopathy 2006;8(2):131‐3.
Pawar 2015 {published data only}
    1. Pawar D. Management of irritable bowel syndrome with Ranunculacae family. National Journal of Homoeopathy 2015;17(7):12‐13.
Pinto 1999 {published data only}
    1. Pinto G. Case studies ‐ Marylebone health centre action research enquiry. Homoeopath 1999;75:36‐41.
Pohl 2013 {published data only}
    1. Pohl D, Heinrich H, Misselwitz B. Irritable bowel syndrome ‐ Diagnostics and therapy [Reizdarmsyndrom ‐ Diagnostik und Therapie]. Gastroenterologe 2013;8(5):417‐24.
Slade 2003 {published data only}
    1. Slade N. Homeopatic casebook. Homeopathy and colitis. Positive Health 2003;86:25‐8.
Turner 2008 {published data only}
    1. Turner R. Homeopathic approaches to irritable bowel syndrome (IBS). Positive Health 2008;146:18‐21.
White 1999 {published data only}
    1. White A. Irritable bowel syndrome. Complementary Medicine Bulletin 1999;1(6):1‐2.

Additional references

Agrawal 2006
    1. Agrawal A, Whorwell PJ. Irritable bowel syndrome: diagnosis and management. BMJ 2006;332(7536):280‐3. - PMC - PubMed
Akehurst 2002
    1. Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, et al. Health‐related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002;20(7):455‐62. - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. - PMC - PubMed
Begg 1996
    1. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting randomized controlled trials The CONSORT statement. JAMA 1996;276(8):637‐9. - PubMed
Dantas 2000
    1. Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. British Homoeopathic Journal 2000;89(Supplement 1):S35‐8. - PubMed
Downs 1998
    1. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non‐randomised studies of health care interventions. Journal of Epidemiology and Community Health 1998;52(6):377‐84. - PMC - PubMed
Drossman 2016
    1. Drossman DA, Hasler WL. Rome IV‐functional GI disorders: disorders of gut‐brain interaction. Gastroenterology 2016;150(6):1257–1261. - PubMed
Gariboldi 2009
    1. Gariboldi S, Palazzo M, Zanobbio L, Dusio GF, Mauro V, Solimene U, et al. Low dose oral administration of cytokines for treatment of allergic asthma. Pulmonary Pharmacology and Therapeutics 2009;22(6):497‐510. - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Linde 1997
    1. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges L, et al. Are the clinical effects of homeopathy placebo effects? A meta‐analysis of placebo controlled trials. Lancet 1997;350(9081):834‐43. - PubMed
Longstreth 2007
    1. Longstreth GF. Avoiding unnecessary surgery in irritable bowel syndrome. Gut 2007;56(5):608‐10. - PMC - PubMed
Mathie 2006
    1. Mathie RT, Robinson TW. Outcomes from homeopathic prescribing in medical practice: A prospective, research‐targeted, pilot study. Homeopathy 2006;95(4):199‐205. - PubMed
McPherson 2012
    1. MacPherson H, Tilbrook H, Bland JM, Bloor K, Brabyn S, Cox H, et al. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterology 2012;12:150. - PMC - PubMed
Mearin 2006
    1. Mearin F, Badía X, Balboa A, Benavent J, Caballero AM, Domínguez‐Muñoz E, et al. Predictive factors of irritable bowel syndrome improvement: 1‐year prospective evaluation of 400 patients. Alimentary Pharmacology and Therapeutics 2006;23(6):815‐26. - PubMed
Montagnier 2009
    1. Montagnier L, Aïssa J, Ferris S, Montagnier JL, Lavallée C. Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdisciplinary Sciences, Computational Life Sciences 2009;1(2):81‐90. - PubMed
Reeves 2011
    1. Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Ruepert 2011
    1. Ruepert L, Quartero AO, Wit NJ, Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD003460.pub3] - DOI - PMC - PubMed
Schultz 2010
    1. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology 2010;63(8):834‐40. - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 2011. Vol. 5.1.0, The Cochrane Collaboration, 2011.
Shang 2005
    1. Shang AJ, Huwiler‐Muntene MD, Narety C, Juni P, Dorig S, Sterne JA, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo‐controlled trials of homoeopathy and allopathy. Lancet 2005;366(9487):726‐32. - PubMed
Spence 2005
    1. Spence DS, Thompson EA, Barron SJ. Homeopathic treatment for chronic disease: a 6 year, university‐hospital outpatient observational study. Journal of Alternative and Complementary Medicine 2005;11(5):793‐8. - PubMed
Spiller 2007
    1. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56(12):1770‐98. - PMC - PubMed
Thomas 2001
    1. Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complementary Therapies in Medicine 2001;9(1):2‐11. - PubMed
Thompson 2000
    1. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000;46(1):78‐82. - PMC - PubMed
Vithoulkas 1980
    1. Vithoulkas G. The Science of Homeopathy. New York: Grove Press, 1980.
Williams 2007
    1. Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, Demery G, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 2007;56 Suppl 1:1‐113. - PMC - PubMed
Zijdenbos 2009
    1. Zijdenbos IL, Wit NJ, Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006442.pub2] - DOI - PubMed

References to other published versions of this review

Peckham 2012
    1. Peckham EJ, Nelson EA, Greenhalgh J, Cooper K, Roberts ER, Agrawal A. Homeopathy for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD009710] - DOI - PubMed

Publication types